Program leverages novel miRARE platform technology used to control transgene expression on a cellular basis TSHA-102 anticipated to submit Investigational New Drug application in 2021…
Program leverages novel miRARE platform technology used to control transgene expression on a cellular basis TSHA-102 anticipated to submit Investigational New Drug application in 2021…